Apoptotic and anti-angiogenic effects of propolis against human bladder cancer: molecular docking and in vitro screening

References

• Abd El Megid, A.D., et al., 2018. Biochemical role of zinc oxide and propolis nanoparticles in protection rabbits against coccidiosis. Benha veterinary medical journal, 34 (1), 314–328.
   Google Scholar
• Afkhamizadeh, M., et al., 2018. Topical propolis improves wound healing in patients with diabetic foot ulcer: a randomized controlled trial. Natural product research, 32 (17), 2096–2099.
   PubMed Web of Science ®Google Scholar
• Bankova, V., 2005. Recent trends and important developments in propolis research. Evidence-based complementary and alternative medicine : eCAM, 2 (1), 29–32.
   PubMed Web of Science ®Google Scholar
• Benković, V., et al., 2008. Evaluation of the radioprotective effects of propolis and flavonoids in gamma-irradiated mice: the alkaline comet assay study. Biological & pharmaceutical bulletin, 31 (1), 167–172.
   PubMed Web of Science ®Google Scholar
• Bertz, S., et al., 2014. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer. European urology, 65 (1), 218–226.
   PubMed Web of Science ®Google Scholar
• Boittier, E.D., et al., 2020. Assessing molecular docking tools to guide targeted drug discovery of CD38 inhibitors. International journal of molecular sciences, 21 (15), 5183.
   Web of Science ®Google Scholar
• Clem, R.J., et al., 1998. Modulation of cell death by Bcl-XL through caspase interaction. Proceedings of the national academy of sciences of the United States of America, 95 (2), 554–559.
   PubMed Web of Science ®Google Scholar
• Dean, P.N. and Jett, J.H., 1974. Mathematical analysis of DNA distributions derived from flow microfluorometry. The journal of cell biology, 60 (2), 523–527.
   PubMed Web of Science ®Google Scholar
• Elmore, S., 2007. Apoptosis: a review of programmed cell death. Toxicologic pathology, 35 (4), 495–516.
   PubMed Web of Science ®Google Scholar
• Freires, I.A., de Alencar, S.M., and Rosalen, P.L., 2016. A pharmacological perspective on the use of Brazilian Red Propolis and its isolated compounds against human diseases. European journal of medicinal chemistry, 110, 267–279.
   PubMed Web of Science ®Google Scholar
• Frozza, C.O., et al., 2013. Chemical characterization, antioxidant and cytotoxic activities of Brazilian red propolis. Food and chemical toxicology, 52, 137–142.
   PubMed Web of Science ®Google Scholar
• Gabellini, C., Trisciuoglio, D., and Del Bufalo, D., 2017. Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain. Carcinogenesis, 38 (6), 579–587.
   PubMed Web of Science ®Google Scholar
• Godwin, J.L., Hoffman-Censits, J., and Plimack, E., 2018. Recent developments in the treatment of advanced bladder cancer. Urologic oncology, 36 (3), 109–114.
   PubMed Web of Science ®Google Scholar
• Gotink, K.J. and Verheul, H.M., 2010. Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? Angiogenesis, 13 (1), 1–14.
   PubMed Web of Science ®Google Scholar
• Hegazi, A.G. and Abd El Hady, F.K., 2002. Egyptian propolis: 3. Antioxidant, antimicrobial activities and chemical composition of propolis from reclaimed lands. Zeitschrift fur Naturforschung C. Zeitschrift fur naturforschung. C, journal of biosciences, 57 (3–4), 395–402.
   PubMed Web of Science ®Google Scholar
• Hegazi, A.G. and El Hady, F.K., 2001. Egyptian propolis: 1-antimicrobial activity and chemical composition of Upper Egypt propolis. Zeitschrift fur Naturforschung C. Zeitschrift fur naturforschung. C, journal of biosciences, 56 (1–2), 82–88.
   PubMed Web of Science ®Google Scholar
• Huang, S., et al., 2014. Recent advances in the chemical composition of propolis. Molecules, 19 (12), 19610–19632.
   PubMed Web of Science ®Google Scholar
• Jin, D., et al., 2015. Catalpol inhibited the proliferation of T24 human bladder cancer cells by inducing apoptosis through the blockade of Akt-mediated anti-apoptotic signaling. Cell biochemistry and biophysics, 71 (3), 1349–1356.
   PubMed Web of Science ®Google Scholar
• Kim, S., et al., 2002. Inhibition of endothelial cell survival and angiogenesis by protein kinase A. The journal of clinical investigation, 110 (7), 933–941.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy, A. and Jimeno, A., 2017. Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers. Drugs of today (orontoa, Spain : 1998), 53 (4), 217–237.
   PubMed Web of Science ®Google Scholar
• Machado, C.S., et al., 2016. Comparative study of chemical composition and biological activity of yellow, green, brown, and red Brazilian propolis. Evidence-based complementary and alternative medicine, 2016, 1–11.
   Web of Science ®Google Scholar
• Martin, S.J., Henry, C.M., and Cullen, S.P., 2012. A perspective on mammalian caspases as positive and negative regulators of inflammation. Molecular cell, 46 (4), 387–397.
   PubMed Web of Science ®Google Scholar
• Meng, X.Y., et al., 2011. Molecular docking: a powerful approach for structure-based drug discovery. Current computer-aided drug design, 7 (2), 146–157.
   PubMed Web of Science ®Google Scholar
• Niswender, C.M., et al., 2002. Protein engineering of protein kinase A catalytic subunits results in the acquisition of novel inhibitor sensitivity. The journal of biological chemistry, 277 (32), 28916–28922.
   PubMed Web of Science ®Google Scholar
• Novak, E.M., et al., 2014. Antitumoural activity of Brazilian red propolis fraction enriched with xanthochymol and formononetin: an in vitro and in vivo study. Journal of functional foods, 11, 91–102.
   Web of Science ®Google Scholar
• Pinzi, L. and Rastelli, G., 2019. Molecular docking: shifting paradigms in drug discovery. International journal of molecular sciences, 20 (18), 4331.
   PubMed Web of Science ®Google Scholar
• Przybyłek, I. and Karpiński, T.M., 2019. Antibacterial properties of propolis. Molecules (molecules), 24 (11), 2047.
   PubMed Web of Science ®Google Scholar
• Puthli, A., Tiwari, R., and Mishra, K.P., 2013. Biochanin A enhances the radiotoxicity in colon tumor cells in vitro. Journal of environmental pathology, toxicology and oncology: official organ of the international society for environmental toxicology and cancer, 32, 189–203.
   PubMedGoogle Scholar
• Ramchurren, N., Cooper, K., and Summerhayes, I.C., 1995. Molecular events underlying schistosomiasis-related bladder cancer. International journal of cancer, 62 (3), 237–244.
   PubMed Web of Science ®Google Scholar
• Siegel, R.L., Miller, K.D., and Jemal, A., 2017. Cancer statistics, 2017. CA: a cancer journal for clinicians, 67, 7–30.
   PubMed Web of Science ®Google Scholar
• Teixeira da Silva, J.A., et al., 2014. In vitro conservation of Dendrobium germplasm. Plant cell reports, 33 (9), 1413–1423.
   PubMed Web of Science ®Google Scholar
• Tugues, S., et al., 2011. Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer. Molecular aspects of medicine, 32 (2), 88–111.
   PubMed Web of Science ®Google Scholar
• Vandeveer, A.J., et al., 2016. Systemic immunotherapy of non-muscle invasive mouse bladder cancer with avelumab, an anti-PD-L1 immune checkpoint inhibitor. Cancer immunology research, 4 (5), 452–462.
   PubMed Web of Science ®Google Scholar
• Yafi, F.A., North, S., and Kassouf, W., 2011. First- and second-line therapy for metastatic urothelial carcinoma of the bladder. Current oncology (Toronto, Ont), 18, e25–e34.
   Web of Science ®Google Scholar
• Zhang, W., et al., 2019. Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy. Annals of translational medicine, 7 (18), 431.
   PubMed Web of Science ®Google Scholar
• Zheng, F., et al., 2019. CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression. Cancer letters, 460, 139–151.
   PubMed Web of Science ®Google Scholar
• Zhu, Q., et al., 2019. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits bladder cancer cell growth via the mitochondrial apoptosis and JNK pathways. Toxicology and applied pharmacology, 371, 41–54.
   PubMed Web of Science ®Google Scholar